Reply to Dubbert and von Bünau, "A Probiotic Friend".
作者信息
Nougayrède Jean-Philippe, Oswald Eric
机构信息
IRSD, INSERM, INRAE, Université de Toulouse, ENVT, Toulouse, France.
出版信息
mSphere. 2021 Dec 22;6(6):e0090621. doi: 10.1128/msphere.00906-21.
Abstract
摘要
相似文献
1
Reply to Dubbert and von Bünau, "A Probiotic Friend".对达伯特和冯·比瑙《一位益生菌朋友》的回复。
mSphere. 2021 Dec 22;6(6):e0090621. doi: 10.1128/msphere.00906-21.
2
Reply to von Bünau et al. Comment on "Depoorter, L.; Vandenplas, Y. Probiotics in Pediatrics. A Review and Practical Guide. 2021, , 2176".回复 von Bünau 等人的评论“Depoorter, L.; Vandenplas, Y. 儿科益生菌。综述和实用指南。2021, 2176”。
Nutrients. 2022 Feb 9;14(4):725. doi: 10.3390/nu14040725.
3
A Probiotic Friend.一位益生菌朋友。
mSphere. 2021 Dec 22;6(6):e0085621. doi: 10.1128/mSphere.00856-21.
4
Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease: REPLY from original authors Biguzzi et al.血管性血友病患者中血管性血友病因子和凝血因子 VIII 水平随年龄增长而升高：原作者比古齐等人的回复
J Thromb Haemost. 2021 Jan;19(1):310. doi: 10.1111/jth.15150.
5
Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Reply.重组血管性血友病因子用于接受择期手术的重度血管性血友病患者的3期研究：回复
J Thromb Haemost. 2019 Aug;17(8):1405-1406. doi: 10.1111/jth.14545.
6
von Willebrand factor: factor VIII protector and friend.
J Thromb Haemost. 2012 Nov;10(11):2324-7. doi: 10.1111/j.1538-7836.2012.04922.x.
7
Reply: Antibody-Based Protection of von Willebrand Factor Degradation.回复：基于抗体对血管性血友病因子降解的保护作用。
JACC Heart Fail. 2016 Jun;4(6):518-9. doi: 10.1016/j.jchf.2016.01.010.
8
Von Willebrand factor for the liver: Friend or foe?肝脏的血管性血友病因子：朋友还是敌人？
Hepatology. 2018 May;67(5):2061. doi: 10.1002/hep.29818.
9
The Y/C1584 mutation of von Willebrand factor in type 2M von Willebrand disease: frequency and clearance of von Willebrand factor.2M型血管性血友病中血管性血友病因子的Y/C1584突变：血管性血友病因子的频率及清除情况
Br J Haematol. 2005 Aug;130(3):462-3. doi: 10.1111/j.1365-2141.2005.05637.x.
10
Review of von Willebrand Disease and Acquired von Willebrand Syndrome for Patients Undergoing Cardiac Surgery.接受心脏手术患者的血管性血友病和获得性血管性血友病综合征综述
J Cardiothorac Vasc Anesth. 2019 Dec;33(12):3446-3457. doi: 10.1053/j.jvca.2019.08.025. Epub 2019 Aug 24.
引用本文的文献
1
Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster.缺乏大肠杆菌素基因簇的活体细菌治疗底盘的稳健性能。
PLoS One. 2023 Feb 2;18(2):e0280499. doi: 10.1371/journal.pone.0280499. eCollection 2023.
2
High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917.高质量的益生菌大肠杆菌 Nissle 1917 的基因组规模代谢网络重建。
BMC Bioinformatics. 2022 Dec 30;23(1):566. doi: 10.1186/s12859-022-05108-9.
本文引用的文献
1
A Probiotic Friend.一位益生菌朋友。
mSphere. 2021 Dec 22;6(6):e0085621. doi: 10.1128/mSphere.00856-21.
2
Mechanistic dissection unmasks colibactin as a prevalent mutagenic driver of cancer.机制剖析揭示大肠杆菌素是癌症普遍的诱变驱动因素。
Cancer Cell. 2021 Nov 8;39(11):1439-1441. doi: 10.1016/j.ccell.2021.10.010.
3
The Mutagenic Impact of Environmental Exposures in Human Cells and Cancer: Imprints Through Time.环境暴露对人类细胞和癌症的致突变影响：随时间的印记
Front Genet. 2021 Oct 20;12:760039. doi: 10.3389/fgene.2021.760039. eCollection 2021.
4
A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917.毒性朋友：益生菌菌株大肠杆菌 Nissle 1917 的遗传毒性和致突变活性。
mSphere. 2021 Aug 25;6(4):e0062421. doi: 10.1128/mSphere.00624-21. Epub 2021 Aug 11.
5
Amending microbiota by targeting intestinal inflammation with TNF blockade attenuates development of colorectal cancer.靶向肠道炎症的 TNF 阻断可改变微生物群，从而减轻结直肠癌的发生。
Nat Cancer. 2020 Jul;1(7):723-734. doi: 10.1038/s43018-020-0078-7. Epub 2020 Jun 22.
6
Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells.短期接触产 colibactin 的大肠杆菌后基因组畸变转化原代结肠上皮细胞。
Nat Commun. 2021 Feb 12;12(1):1003. doi: 10.1038/s41467-021-21162-y.
7
The Polyphosphate Kinase of Escherichia coli Is Required for Full Production of the Genotoxin Colibactin.大肠杆菌的多聚磷酸盐激酶是产生肠毒素 colibactin 所必需的。
mSphere. 2020 Dec 16;5(6):e01195-20. doi: 10.1128/mSphere.01195-20.
8
Colibactin DNA-damage signature indicates mutational impact in colorectal cancer.肠菌素 DNA 损伤特征表明结直肠癌的突变影响。
Nat Med. 2020 Jul;26(7):1063-1069. doi: 10.1038/s41591-020-0908-2. Epub 2020 Jun 1.
9
No Genotoxicity Is Detectable for Strain Nissle 1917 by Standard In Vitro and In Vivo Tests.通过标准体外和体内试验，未检测到1917株大肠杆菌Nissle的遗传毒性。
Eur J Microbiol Immunol (Bp). 2020 Mar 17;10(1):11-19. doi: 10.1556/1886.2019.00025. eCollection 2020 Apr 7.
10
Mutational signature in colorectal cancer caused by genotoxic pks E. coli.由基因毒性 pks E. coli 引起的结直肠癌中的突变特征。
Nature. 2020 Apr;580(7802):269-273. doi: 10.1038/s41586-020-2080-8. Epub 2020 Feb 27.
Zotero 插件